Shopping Cart
Remove All
Your shopping cart is currently empty
TAT-MEK1, an inhibitor of ERK2, comprises TAT and MEK1 (N-terminal). The TAT component (YGRKKRRQRRR) is a cell-penetrating peptide derived from the human immunodeficiency (HIV-1) transcriptional trans activator (TAT). TAT-MEK1 has an IC50 of 29 μM for ERK2 in vitro [1] [2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | TAT-MEK1, an inhibitor of ERK2, comprises TAT and MEK1 (N-terminal). The TAT component (YGRKKRRQRRR) is a cell-penetrating peptide derived from the human immunodeficiency (HIV-1) transcriptional trans activator (TAT). TAT-MEK1 has an IC50 of 29 μM for ERK2 in vitro [1] [2]. |
| In vitro | TAT-MEK1 (100 μM, 30 min) effectively inhibits luciferase activity in NIH 3T3 and PC12 cells and suppresses ERK2 activation [2]. Western Blot Analysis [2] was conducted on cell lines NIH 3T3 and PC12 with a concentration of 100 μM and an incubation time of 30 minutes, resulting in decreased luciferase and ERK2 activities. |
| Molecular Weight | 3146.77 |
| Formula | C136H241N53O31S |
| Cas No. | 566872-16-0 |
| Sequence | Gly-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Met-Pro-Lys-Lys-Lys-Pro-Thr-Pro-Ile-Gln-Leu-Asn-Pro-NH2 |
| Sequence Short | GYGRKKRRQRRRGMPKKKPTPIQLNP-NH2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.